Skip to main content
SP5007,675.70-0.02%DOW53,463.88-0.21%NASDAQ26,130.20-0.08%BTC$78,784.00+0.17%ETH$2,494.91+1.91%GOLD$4,660.40+0.15%OIL$81.57-0.80%
Smart Investors Daily
Sign InSign Up Free
PB

OTC · PBLA

Panbela Therapeutics, Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Aug 27, 2026, 1:48 AM

SID Score

3.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
97.1K
P/E ratio
-0.01
Dividend yield
0.00%
52-week range
$0.00 – $2.50
Volume
155
Avg. volume
2.38K

Price performance

PBLA price history

1M range · 0 trading sessions · Daily adjusted prices

PBLA does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest PBLA news

The latest Smart Investors Daily articles mentioning PBLA.

Stock researchCompany · Overview

PBLA research

Overview

Company profile and research snapshot.

Company profile

PANBELA THERAPEUTICS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
7
PBLA recent ratings
DateFirmRatingTarget
Aug 15, 2024HC Wainwright & Co.Neutral—
Jun 24, 2024HC Wainwright & Co.Neutral—
May 16, 2024HC Wainwright & Co.Neutral—
Apr 2, 2024HC Wainwright & Co.Buy—
Mar 27, 2024Roth MKMBuy—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · May 15, 2024

Panbela Provides Business Update and Reports Q1 2024 Financial Results

MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended March 31, 2024. As previously announced, management is hosting earnings call today at 4:30 p.m. ET.

GlobeNewswire Inc. · May 1, 2024

Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024

MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on May 15, 2024, at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2024.

GlobeNewswire Inc. · Apr 16, 2024

Panbela Announces Transfer to OTCQB Market

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that its common stock has been approved for quotation on the OTCQB market. Panbela’s common stock will be eligible for quotation on the OTCQB starting on April 17, 2024, under the symbol “PBLA.”

Benzinga · Feb 23, 2024

Top 4 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. ProSomnus, Inc. (NASDAQ: OSA) On Feb. 22, ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By